CONMED Corporation (NASDAQ:CNMD) declared a quarterly dividend on Tuesday, August 29th, RTT News reports. Investors of record on Friday, September 15th will be given a dividend of 0.20 per share by the medical technology company on Thursday, October 5th. This represents a $0.80 annualized dividend and a yield of 1.61%. The ex-dividend date of this dividend is Thursday, September 14th.

CONMED Corporation (NASDAQ:CNMD) traded up 0.06% during trading on Friday, reaching $49.56. The company had a trading volume of 83,364 shares. The stock has a 50 day moving average of $49.55 and a 200-day moving average of $48.08. CONMED Corporation has a 12-month low of $37.60 and a 12-month high of $52.82. The stock has a market capitalization of $1.38 billion, a P/E ratio of 88.66 and a beta of 0.68.

CONMED Corporation (NASDAQ:CNMD) last issued its quarterly earnings data on Wednesday, July 26th. The medical technology company reported $0.41 earnings per share (EPS) for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.41. The company had revenue of $197.20 million for the quarter, compared to analyst estimates of $194.50 million. CONMED Corporation had a net margin of 2.02% and a return on equity of 8.38%. CONMED Corporation’s revenue was up 2.0% compared to the same quarter last year. During the same period last year, the company posted $0.47 earnings per share. On average, analysts forecast that CONMED Corporation will post $1.87 earnings per share for the current fiscal year.

In other CONMED Corporation news, Director Jo Ann Golden sold 3,000 shares of CONMED Corporation stock in a transaction on Monday, August 14th. The shares were sold at an average price of $50.00, for a total value of $150,000.00. Following the transaction, the director now directly owns 19,782 shares of the company’s stock, valued at $989,100. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Dirk Kuyper sold 1,000 shares of CONMED Corporation stock in a transaction on Tuesday, June 13th. The stock was sold at an average price of $52.24, for a total transaction of $52,240.00. Following the completion of the transaction, the director now directly owns 10,739 shares in the company, valued at $561,005.36. The disclosure for this sale can be found here. 2.62% of the stock is currently owned by insiders.

Several equities analysts have issued reports on CNMD shares. BidaskClub lowered shares of CONMED Corporation from a “sell” rating to a “strong sell” rating in a report on Sunday, August 20th. Zacks Investment Research lowered shares of CONMED Corporation from a “hold” rating to a “sell” rating in a report on Tuesday, June 27th. Needham & Company LLC reaffirmed a “buy” rating and issued a $57.00 price target on shares of CONMED Corporation in a report on Friday, September 1st. KeyCorp reaffirmed a “hold” rating on shares of CONMED Corporation in a report on Friday, August 25th. Finally, TheStreet raised shares of CONMED Corporation from a “c+” rating to a “b-” rating in a report on Thursday, August 3rd. Two equities research analysts have rated the stock with a sell rating, three have issued a hold rating and one has issued a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and an average price target of $49.33.

TRADEMARK VIOLATION NOTICE: “CONMED Corporation (CNMD) To Go Ex-Dividend on September 14th” was posted by Daily Political and is owned by of Daily Political. If you are viewing this story on another site, it was copied illegally and republished in violation of US and international trademark & copyright law. The correct version of this story can be read at https://www.dailypolitical.com/2017/09/09/conmed-corporation-cnmd-to-go-ex-dividend-on-september-14th.html.

About CONMED Corporation

CONMED Corporation is a medical technology company. The Company is engaged in the development, manufacturing and sale on a global basis of surgical devices and related equipment. The Company provides surgical devices and equipment for minimally invasive procedures. The Company’s products are used by surgeons and physicians in a range of specialties, including orthopedics, general surgery, gynecology, neurosurgery and gastroenterology.

Dividend History for CONMED Corporation (NASDAQ:CNMD)

Receive News & Ratings for CONMED Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CONMED Corporation and related companies with MarketBeat.com's FREE daily email newsletter.